Treatment of Bendamustine and Prednisone in patients with newly diagnosed multiple myeloma results in superior complete response rate, prolonged time to treatment failure and improved quality of life compared to treatment with Melphalan and Prednisone—a randomized phase III study of the East German Study Group of Hematology and Oncology (OSHO) W. PönischP. S. MitrouD. Niederwieser Original Paper 10 January 2006 Pages: 205 - 212
Clinical significance of a wide excision policy for sacrococcygeal chordoma Shunzo OsakaOsamu KodohJunnosuke Ryu Original Paper 16 December 2005 Pages: 213 - 218
Methylenetetrahydrofolate reductase polymorphism and minor increase of risk for oral cancer E. VairaktarisC. YapijakisF. W. Neukam Original Paper 20 December 2005 Pages: 219 - 222
5-(4-Chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxygen species-dependent manner to suppress human lung cancer growth Eunmyong LeeMoon-Kyung ChoiSoo-Jeong Lim Original Paper 13 December 2005 Pages: 223 - 233
Short-term monitoring of cognitive functions before and during the first course of treatment Barbara EberhardtStefan DilgerWolfgang H. R. Miltner Original Paper 14 January 2006 Pages: 234 - 240
Decreased galectin-3 expression during the progression of cervical neoplasia Jeong-Won LeeSang Yong SongDuk-Soo Bae Original Paper 21 December 2005 Pages: 241 - 247
Observation of circulating tumour cells in patients with non-small cell lung cancer by real-time fluorescent quantitative reverse transcriptase-polymerase chain reaction in peroperative period Ming Jian GeDe ShiLiang Bin Li Original Paper 01 December 2005 Pages: 248 - 256
Chemically modified heparin inhibits the in vitro adhesion of nonsmall cell lung cancer cells to P-selectin Yanguang GaoMin WeiXianlu Zeng Original Paper 06 December 2005 Pages: 257 - 264
Pre-existing T-cell immunity against mucin-1 in breast cancer patients and healthy volunteers Brigitte GückelChristine RentzschDiethelm Wallwiener Rapid Communication 22 December 2005 Pages: 265 - 274
